Oslo, May 3: Pre-Diagnostics are a Norwegian start-up developing a non-invasive Alzheimer’s test that measures intracellular changes that could give earlier warning of disease than blood or plasma-based assays. Ashley Yeo interviewed recently for this in-depth profile in Medtech-Insight www.medtech.pharma.intelligence.com.